Neuphoria Therapeutics Inc. revenue breakdown overview

Neuphoria Therapeutics Inc. revenue for the last year amounted to 958.61 k USD, the most of which — 14.83 k USD — came from its highest performing source at the moment, Allosteric Ion Channel Modulators, the year earlier bringing 191.19 k USD. The greatest contribution to the revenue figure was made by Australia — last year it brought Neuphoria Therapeutics Inc. 14.83 k USD, and the year before that — 191.19 k USD.